Jounce Therapeutics Inc

NASDAQ:JNCE  
9.01
0.00 (0.00%)
Equity Financing / Related, Initial Public Offerings

Jounce Therapeutics Announces Proposed Offering Of Common Stock

Published: 03/09/2021 22:53 GMT
Jounce Therapeutics Inc (JNCE) - Jounce Therapeutics Announces Proposed Offering of Common Stock.
Jounce Therapeutics - Proceeds of Offering Are Expected to Be Used to Fund Ongoing and Planned Clinical Trials, Including Innate Trial for Jtx-8064.
Jounce Therapeutics Inc - Proceeds of Offering Are Expected to Fund Research and Development to Advance Jounce's Pipeline.